Expense Ratio Rating
3 /10
Expense Rating
0 /10
Market Score
0 /10
Category Score
8 /10
Market Size
0 /10
$TVVAX Alternatives
Different Funds
We found 8,043 US Stocks Large Value funds. Here they are ordered by FI Score.
- pufbx
- Mutual Fund
- Sector Equity
- Financial Services
PGIM Jennison Financial Services Fund- Class B
Expenses: 2.31% (Better than 0% of similar funds)
This is a bad choice for a Financial Services Sector Equity fund. See why »
- ryvnx
- Mutual Fund
- Alternative
- Inverse
Rydex Inverse NASDAQ-100® 2x Strategy Fund Class H
Expenses: 1.88% (Better than 0% of similar funds)
This is a bad choice for a Inverse Alternative fund. See why »
- sdmgx
- Mutual Fund
- International Stocks
- Emerging Markets
Sit Developing Markets Growth Fund
Expenses: 1.40% (Better than 0% of similar funds)
This is a bad choice for a Emerging Markets International Stocks fund. See why »
- spdcx
- Mutual Fund
- Allocation
- All-In-One
DWS Multi-Asset Conservative Allocation Fund - Class C
Expenses: 1.41% (Better than 0% of similar funds)
This is a bad choice for a All-In-One Allocation fund. See why »
- rgscx
- Mutual Fund
- Allocation
- Total World
AllianzGI Global Small-Cap Fund Class C
Expenses: 2.37% (Better than 0% of similar funds)
This is a bad choice for a Total World Allocation fund. See why »
- rmicx
- Mutual Fund
- Allocation
- All-In-One
RiverFront Asset Allocation Moderate Class C
Expenses: 1.25% (Better than 0% of similar funds)
This is a bad choice for a All-In-One Allocation fund. See why »
- ryahx
- Mutual Fund
- Alternative
- Leveraged Equities
Rydex Mid-Cap 1.5x Strategy Fund Class A
Expenses: 1.75% (Better than 0% of similar funds)
This is a bad choice for a Leveraged Equities Alternative fund. See why »
- rybox
- Mutual Fund
- Sector Equity
- Healthcare
Rydex Biotechnology Fund Class A
Expenses: 1.71% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »
- ryoax
- Mutual Fund
- Sector Equity
- Healthcare
Rydex Biotechnology Fund Class H
Expenses: 1.71% (Better than 0% of similar funds)
This is a bad choice for a Healthcare Sector Equity fund. See why »